We found a trend toward shorter progression-free survival (PFS) but did not reach statistical significance for germline P/LP mutation carriers (p = 0.084; Figure 3 A).
← all excerpts
Inherited mutations in Chinese patients with upper tract urothelial carcinoma.
1
0.0840
0.0840